Literature DB >> 8995586

Spontaneous myopathy in the SJL/J mouse: pathology and strength loss.

A H Weller1, S A Magliato, K P Bell, N L Rosenberg.   

Abstract

Myopathy has been found to develop spontaneously in 100% of SJL/J mice between 6 and 8 months of age. Extent of muscular involvement and mouse strength were quantified in SJL/J mice and Balb/c control mice 2-16 months old. Muscle from young SJL/J mice exhibited histopathological abnormalities and occasional inflammatory infiltrate. By 6 months, 78% of SJL/J mice had developed active myopathy. By 8 months, all SJL/J mice examined had active disease with a mean of 12.9% of muscle fibers affected. Replacement of muscle fibers by fat and/or collagen began at 10 months and was pronounced by 14 months. Significant decreases in strength scores (total body pulling force) at 6 months and 10 months of age reflected the onset of active myopathy and the onset of muscle degeneration, respectively. The spontaneous onset and 100% incidence of myopathy in the SJL/J mouse line should provide a useful model for idiopathic myopathy.

Entities:  

Mesh:

Year:  1997        PMID: 8995586     DOI: 10.1002/(sici)1097-4598(199701)20:1<72::aid-mus10>3.0.co;2-3

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

Review 1.  New insights into the functional role of the rheumatoid arthritis shared epitope.

Authors:  Denise E de Almeida; Song Ling; Joseph Holoshitz
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

2.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Authors:  Monica H Kristiansson; Vadiraja B Bhat; I Ramesh Babu; John S Wishnok; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2007-03-28       Impact factor: 4.466

Review 3.  Aging and the musculoskeletal system.

Authors:  D Hamerman
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

4.  Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies.

Authors:  P C G Onofre-Oliveira; A L F Santos; P M Martins; D Ayub-Guerrieri; M Vainzof
Journal:  Neuromolecular Med       Date:  2012-02-24       Impact factor: 3.843

Review 5.  Pathogenesis of neuroimmunologic diseases. Experimental models.

Authors:  C S Constantinescu; B Hilliard; T Fujioka; M K Bhopale; D Calida; A M Rostami
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 6.  A role for calreticulin in the pathogenesis of rheumatoid arthritis.

Authors:  Joseph Holoshitz; Denise E De Almeida; Song Ling
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy.

Authors:  Jennifer R Levy; Kevin P Campbell
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

8.  Assessment of disease activity in muscular dystrophies by noninvasive imaging.

Authors:  Katie K Maguire; Leland Lim; Sedona Speedy; Thomas A Rando
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

9.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

10.  Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.

Authors:  Tatiana V Cohen; Jonathan E Cohen; Terence A Partridge
Journal:  Neuromuscul Disord       Date:  2012-05-03       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.